Publications by authors named "Giulia Fulci"

Claim this Profile
P
Patient-reported outcomes with belantamab mafodotin, pomalidomide, and dexamethasone versus bortezomib, pomalidomide, and dexamethasone in patients with relapsed or refractory multiple myeloma (DREAMM-8): a phase 3, open-label, randomised controlled trial.
Meletios A Dimopoulos, Meral Beksac, Ludek Pour, Sosana Delimpasi, Vladimir Vorobyev, Giulia Fulci

Lancet Haematol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Belantamab Mafodotin with Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: A Comprehensive Exposure-Response Analysis of the DREAMM-8 Study.
Patrick Hanafin, Yu Liu Ho, Theodoros Papathanasiou, Giulia Fulci, Neal Sule

Target Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Belantamab Mafodotin, Pomalidomide, and Dexamethasone in Multiple Myeloma.
Meletios Athanasios Dimopoulos, Meral Beksac, Ludek Pour, Sosana Delimpasi, Vladimir Vorobyev, Giulia Fulci

N Engl J Med· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fear of recurrence, emotional well-being and quality of life among long-term advanced ovarian cancer survivors.
Kathryn Osann, Lari Wenzel, Chelsea McKinney, Lynne Wagner, David Cella, Giulia Fulci

Gynecol Oncol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myeloperoxidase exerts anti-tumor activity in glioma after radiotherapy.
Muhammad Ali, Giulia Fulci, Mantas Grigalavicius, Benjamin Pulli, Anning Li

Neoplasia· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of Life and Adverse Events: Prognostic Relationships in Long-Term Ovarian Cancer Survival.
Lari Wenzel, Kathryn Osann, Chelsea McKinney, David Cella, Giulia Fulci

J Natl Cancer Inst· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptomic signature of painful human neurofibromatosis type 2 schwannomas.
Phanidhar Kukutla, Sherif G Ahmed, Daniel M DuBreuil, Ahmed Abdelnabi, Murat Cetinbas, Giulia Fulci

Ann Clin Transl Neurol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene therapy with apoptosis-associated speck-like protein, a newly described schwannoma tumor suppressor, inhibits schwannoma growth in vivo.
Sherif G Ahmed, Ahmed Abdelnabi, Casey A Maguire, Mohamed Doha, Jessica E Sagers, Giulia Fulci

Neuro Oncol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methods for Systematic Identification of Membrane Proteins for Specific Capture of Cancer-Derived Extracellular Vesicles.
Mikołaj Piotr Zaborowski, Kyungheon Lee, Young Jeong Na, Alessandro Sammarco, Xuan Zhang, Giulia Fulci

Cell Rep· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct saturation-corrected chemical exchange saturation transfer MRI of glioma: Simplified decoupling of amide proton transfer and nuclear overhauser effect contrasts.
Iris Yuwen Zhou, Enfeng Wang, Jerry S Cheung, Dongshuang Lu, Yang Ji, Giulia Fulci

Magn Reson Med· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative chemical exchange saturation transfer (CEST) MRI of glioma using Image Downsampling Expedited Adaptive Least-squares (IDEAL) fitting.
Iris Yuwen Zhou, Enfeng Wang, Jerry S Cheung, Xiaoan Zhang, Giulia Fulci

Sci Rep· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surface biotinylation of cytotoxic T lymphocytes for in vivo tracking of tumor immunotherapy in murine models.
Anning Li, Yue Wu, Jenny Linnoila, Benjamin Pulli, Cuihua Wang, Giulia Fulci

Cancer Immunol Immunother· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The in vivo therapeutic efficacy of the oncolytic adenovirus Delta24-RGD is mediated by tumor-specific immunity.
Anne Kleijn, Jenneke Kloezeman, Elike Treffers-Westerlaken, Giulia Fulci, Sieger Leenstra

PLoS One· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained, low-dose intraperitoneal cisplatin improves treatment outcome in ovarian cancer mouse models.
Hongye Ye, Laura M Tanenbaum, Young Jeong Na, Aikaterini Mantzavinou, Giulia Fulci

J Control Release· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishing the Lysine-rich Protein CEST Reporter Gene as a CEST MR Imaging Detector for Oncolytic Virotherapy.
Christian T Farrar, Jason S Buhrman, Guanshu Liu, Anne Kleijn, Martine L M Lamfers, Giulia Fulci

Radiology· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The therapeutic efficacy of the oncolytic virus Delta24-RGD in a murine glioma model depends primarily on antitumor immunity.
Anne Kleijn, Jenneke Kloezeman, Elike Treffers-Westerlaken, Giulia Fulci, Sieger Leenstra

Oncoimmunology· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of oncolytic herpes simplex viruses armed with angiostatin and IL-12 enhances antitumor efficacy in human glioblastoma models.
Wei Zhang, Giulia Fulci, Hiroaki Wakimoto, Tooba A Cheema, Jason S Buhrman

Neoplasia· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regression of schwannomas induced by adeno-associated virus-mediated delivery of caspase-1.
Shilpa Prabhakar, Mehran Taherian, Davide Gianni, Thomas J Conlon, Giulia Fulci

Hum Gene Ther· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bevacizumab with angiostatin-armed oHSV increases antiangiogenesis and decreases bevacizumab-induced invasion in U87 glioma.
Wei Zhang, Giulia Fulci, Jason S Buhrman, Anat O Stemmer-Rachamimov, John W Chen

Mol Ther· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinguishing inflammation from tumor and peritumoral edema by myeloperoxidase magnetic resonance imaging.
Anne Kleijn, John W Chen, Jason S Buhrman, Gregory R Wojtkiewicz, Yoshiko Iwamoto, Giulia Fulci

Clin Cancer Res· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of HSV oncolytic virotherapy in organotypic cultures.
Giulia Fulci, Brent Passer

Methods Mol Biol· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of tumor microenvironment modulation on the efficacy of oncolytic virus therapy.
Kazuhiko Kurozumi, Jayson Hardcastle, Roopa Thakur, Ming Yang, Gregory Christoforidis, Giulia Fulci

J Natl Cancer Inst· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Depletion of peripheral macrophages and brain microglia increases brain tumor titers of oncolytic viruses.
Giulia Fulci, Nina Dmitrieva, Davide Gianni, Elisabeth J Fontana, Xiaogang Pan

Cancer Res· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The status of gene therapy for brain tumors.
Giulia Fulci, E Antonio Chiocca

Expert Opin Biol Ther· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclophosphamide increases transgene expression mediated by an oncolytic adenovirus in glioma-bearing mice monitored by bioluminescence imaging.
Martine L M Lamfers, Giulia Fulci, Davide Gianni, Yi Tang, Kazuhiko Kurozumi

Mol Ther· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis